Medicines

Fulltext search

For help on how to get the results you want, see our search tips.

Search results

Categories

Human Remove Human filter

Medicine name

Active substance / international non-proprietary name (INN) / common name

Medicine

Summaries of opinion Remove Summaries of opinion filter Referrals Remove Referrals filter European public assessment reports (EPAR) (136) Apply European public assessment reports (EPAR) filter Withdrawn applications (5) Apply Withdrawn applications filter Paediatric investigation plans (26) Apply Paediatric investigation plans filter Orphan designations (27) Apply Orphan designations filter Direct healthcare professional communication (16) Apply Direct healthcare professional communication filter

Product number

Opinion status

Negative (2) Apply Negative filter Positive (8) Apply Positive filter

Application type

Initial authorisation (6) Apply Initial authorisation filter Post-authorisation (4) Apply Post-authorisation filter

Date of opinion

From:

To:

Referral name

Referral status

European Commission final decision (2) Apply European Commission final decision filter Under evaluation (1) Apply Under evaluation filter

Referral safety status

Yes (1) Apply Yes filter

Referral type

Article 20 procedures (3) Apply Article 20 procedures filter

Referral reference number

Referral decision making model

PRAC-CAT-CHMP-EC (1) Apply PRAC-CAT-CHMP-EC filter

Referral authorisation model

Centrally authorised product(s) (3) Apply Centrally authorised product(s) filter

Referral PRAC recommendation

Risk minimisation measures (1) Apply Risk minimisation measures filter

Referral procedure start date

From:

To:

Referral PRAC recommendation date

From:

To:

Decision date

From:

To:

Medicine type

Biosimilar Remove Biosimilar filter Conditional approval Remove Conditional approval filter Accelerated assessment (3) Apply Accelerated assessment filter Additional monitoring (24) Apply Additional monitoring filter Exceptional circumstances (3) Apply Exceptional circumstances filter Generic (8) Apply Generic filter Orphan medicine (12) Apply Orphan medicine filter

Related medicine

Therapeutic area

Last updated

From:

To:

This week This month Last week Last month

First published

From:

To:

13 results

Remove all filtersRemove all filters

Medicine Summaries of opinion Remove Summaries of opinion filter Referrals Remove Referrals filter

Medicine type Conditional approval Remove Conditional approval filter Biosimilar Remove Biosimilar filter

Categories Human Remove Human filter

Sort by

List item

Summary of opinion: Tuznue (updated)

trastuzumab, opinion date: 19/05/2022, Negative, Last updated: 24/06/2022
List item

Summary of opinion: Hervelous (updated)

trastuzumab, opinion date: 19/05/2022, Negative, Last updated: 24/06/2022
List item

Summary of opinion: Retsevmo

selpercatinib, opinion date: 22/04/2022, Positive, Last updated: 22/04/2022
List item

Summary of opinion: Nexpovio

selinexor, opinion date: 19/05/2022, Positive, Last updated: 20/05/2022
List item

Summary of opinion: Crysvita (new)

burosumab, opinion date: 23/06/2022, Positive, Last updated: 24/06/2022
List item

Summary of opinion: Enhertu (new)

trastuzumab deruxtecan, opinion date: 23/06/2022, Positive, Last updated: 24/06/2022
List item

Summary of opinion: Ranivisio (new)

ranibizumab, opinion date: 23/06/2022, Positive, Last updated: 24/06/2022
List item

Summary of opinion: Vegzelma (new)

bevacizumab, opinion date: 23/06/2022, Positive, Last updated: 21/06/2022
List item

Summary of opinion: Roctavian (new)

Valoctocogene roxaparvovec, opinion date: 23/06/2022, Positive, Last updated: 24/06/2022
List item

Summary of opinion: Kinpeygo

budesonide, opinion date: 19/05/2022, Positive, Last updated: 20/05/2022
List item

Referral: Rubraca (updated)

rucaparib, associated names: Rubraca, Article 20 procedures
Status: Under evaluation, Last updated: 24/06/2022
List item

Referral: Zynteglo

betibeglogene autotemcel, associated names: Zynteglo, Article 20 procedures
Status: European Commission final decision, opinion/position date: 22/07/2021, EC decision date: 16/09/2021, Last updated: 11/10/2021
List item

Referral: Lartruvo

olaratumab, associated names: Lartruvo, Article 20 procedures
Status: European Commission final decision, opinion/position date: 31/01/2019, EC decision date: 19/07/2019, Last updated: 22/08/2019

13 results

Summary of opinion: Tuznue (updated)

Summary of opinion: Hervelous (updated)

Summary of opinion: Retsevmo

Summary of opinion: Nexpovio

Summary of opinion: Crysvita (new)

Summary of opinion: Enhertu (new)

Summary of opinion: Ranivisio (new)

Summary of opinion: Vegzelma (new)

Summary of opinion: Roctavian (new)

Summary of opinion: Kinpeygo

Referral: Rubraca (updated)

Referral: Zynteglo

Referral: Lartruvo